Endocrine Drugs

Learning Objectives

By the end of this topic, you should be able to:

• Classify antidiabetic drugs by mechanism and explain how each lowers blood glucose
• Describe the mechanism, onset, and duration of the major insulin types
• Explain the mechanism of metformin and why it does not cause hypoglycemia on its own
• Compare thyroid hormone replacement (levothyroxine) with anti-thyroid drugs (methimazole, PTU)
• Explain the mechanism of action of corticosteroids and the risks of long-term use
• Recognize the major side effects of each endocrine drug class and how they are monitored
• Apply this knowledge to common exam vignettes involving diabetes, thyroid disease, and steroid therapy

Quick Answer

Endocrine drugs are medicines that replace, boost, or block hormones to correct a gland that is doing too little or too much. The three pillars tested most often are antidiabetic drugs (insulin and oral agents that lower blood glucose by different mechanisms), thyroid drugs (levothyroxine replaces a failing thyroid; methimazole and PTU shut down an overactive one), and corticosteroids (synthetic cortisol used for inflammation and adrenal replacement, but dangerous if stopped abruptly or used long-term). They matter because endocrine disease is common, chronic, and dose-sensitive — get the dose or timing wrong and you cause the opposite problem (hypoglycemia, thyroid storm, adrenal crisis).

Insulin and Oral Hypoglycemic Drugs

Insulin

Definition: Insulin is the hormone normally made by pancreatic beta cells that drives glucose out of the blood and into muscle, fat, and liver cells.

Explanation: Insulin binds the insulin receptor (a tyrosine kinase) on target cells, triggering GLUT4 transporters to move to the cell membrane so glucose can enter. It also promotes glycogen, fat, and protein synthesis while suppressing gluconeogenesis in the liver. Because insulin can't be taken orally (it's a protein and would be digested), it's always given by injection or infusion. Preparations differ by how fast they act and how long they last:

Type	Example	Onset	Peak	Duration	Typical use
Rapid-acting	Lispro, Aspart, Glulisine	10-15 min	1-2 hr	3-5 hr	Bolus with meals
Short-acting	Regular insulin	30 min	2-3 hr	6-8 hr	Pre-meal, IV in DKA
Intermediate	NPH	1-2 hr	4-12 hr	12-18 hr	Twice-daily basal
Long-acting	Glargine, Detemir	1-2 hr	minimal peak	20-24 hr	Once-daily basal
Ultra-long	Degludec	1 hr	minimal peak	>42 hr	Basal, flexible timing

Example: A type 1 diabetic uses glargine once daily for background (basal) coverage and lispro before each meal for the glucose spike from food — mimicking normal physiologic insulin secretion.

Real-World Example: In diabetic ketoacidosis, regular insulin is given as a continuous IV infusion because its predictable onset and short duration allow tight, minute-to-minute titration of blood glucose alongside fluids and potassium.

Why It Matters: Insulin is the only antidiabetic drug that works in type 1 diabetes, since these patients have essentially no endogenous insulin. It's also used in type 2 diabetes once oral agents fail.

Common Misunderstanding: Students often think all insulins are interchangeable. In practice, basal and bolus insulins serve different physiologic roles, and mixing up a rapid-acting dose with a long-acting one is a classic dosing error that causes severe hypoglycemia.

Metformin

Definition: Metformin is a biguanide and the first-line oral drug for type 2 diabetes.

Explanation: It primarily works by activating AMP-activated protein kinase (AMPK) in the liver, which reduces hepatic gluconeogenesis (less glucose is made by the liver). It also modestly increases peripheral insulin sensitivity and reduces intestinal glucose absorption. Crucially, metformin does not stimulate insulin release, so it does not cause hypoglycemia when used alone.

Example: A newly diagnosed type 2 diabetic with an HbA1c of 7.5% is started on metformin 500 mg once daily, titrated upward over weeks to reduce GI upset.

Real-World Example: Metformin is held before procedures using IV contrast dye because rare renal impairment from contrast can cause metformin to accumulate and trigger lactic acidosis, a rare but life-threatening complication.

Why It Matters: Metformin lowers HbA1c, doesn't cause weight gain (may cause modest weight loss), and has cardiovascular benefit data — which is why it's first-line over sulfonylureas.

Common Misunderstanding: Many students assume metformin "makes the pancreas release more insulin" like sulfonylureas do. It does not touch beta-cell insulin secretion at all — its action is entirely on reducing hepatic glucose output.

Other Oral Agents (quick reference)

• Sulfonylureas (glipizide, glyburide): close K-ATP channels on beta cells, forcing insulin release — risk of hypoglycemia because they work independent of blood glucose level
• DPP-4 inhibitors (sitagliptin): prevent breakdown of GLP-1, enhancing glucose-dependent insulin release — low hypoglycemia risk
• SGLT2 inhibitors (empagliflozin): block glucose reabsorption in the kidney, causing glucosuria — also give cardiorenal protection
• GLP-1 agonists (semaglutide): mimic incretin hormone, slow gastric emptying, promote satiety and weight loss

Thyroid Drugs

Levothyroxine (T4 replacement)

Definition: Levothyroxine is synthetic T4, used to treat hypothyroidism.

Explanation: It's converted peripherally to the active hormone T3, which enters cells and binds nuclear thyroid hormone receptors to regulate gene transcription and raise basal metabolic rate. Because it has a long half-life (~7 days), it's dosed once daily and takes about 4-6 weeks to reach steady state.

Example: A typical starting dose is 1.6 mcg/kg/day for a young healthy adult, but in elderly patients or those with cardiac disease, you start low (25-50 mcg/day) and titrate slowly to avoid provoking angina or arrhythmia.

Real-World Example: A patient with Hashimoto's thyroiditis takes levothyroxine on an empty stomach, 30-60 minutes before breakfast, because food, calcium, and iron supplements all impair its absorption.

Why It Matters: Dosing is guided by TSH, not by symptoms alone — TSH takes 6-8 weeks to reflect a dose change, so retesting too early gives a misleading result.

Common Misunderstanding: Students often think a higher levothyroxine dose is always "more thyroid replacement = better." Overtreatment suppresses TSH and can cause iatrogenic hyperthyroidism, atrial fibrillation, and bone loss — the goal is a normal TSH, not the lowest one.

Anti-Thyroid Drugs

Definition: Methimazole and propylthiouracil (PTU) are thionamides used to treat hyperthyroidism (e.g., Graves' disease).

Explanation: Both inhibit thyroid peroxidase, the enzyme that iodinates thyroglobulin, blocking new thyroid hormone synthesis. PTU has an extra action: it blocks peripheral conversion of T4 to T3, which is why it's preferred in thyroid storm for a faster clinical effect.

Example: Methimazole is first-line for most Graves' disease because it's dosed once daily and carries a lower risk of hepatotoxicity than PTU.

Real-World Example: PTU is specifically preferred in the first trimester of pregnancy despite its liver risk, because methimazole is associated with a rare but serious fetal scalp defect (aplasia cutis).

Why It Matters: Both drugs carry a risk of agranulocytosis — any patient on these drugs presenting with fever or sore throat needs an urgent white cell count.

Common Misunderstanding: Students confuse anti-thyroid drugs with radioactive iodine (which destroys thyroid tissue) or beta-blockers (which only control adrenergic symptoms like tremor and tachycardia without touching hormone synthesis).

Corticosteroids

Definition: Corticosteroids are synthetic analogs of adrenal cortisol (glucocorticoids like prednisone) or aldosterone (mineralocorticoids like fludrocortisone).

Explanation: Glucocorticoids bind intracellular glucocorticoid receptors, translocate to the nucleus, and alter transcription of genes controlling inflammation — they induce anti-inflammatory proteins (like lipocortin, which inhibits phospholipase A2 and thus the whole arachidonic acid cascade) and suppress pro-inflammatory cytokines. Mineralocorticoids act on the kidney to promote sodium retention and potassium excretion.

Example: Prednisone is used short-term for an asthma exacerbation or long-term (with steroid-sparing agents) for autoimmune diseases like lupus.

Real-World Example: A patient on prednisone for 3 months who stops it abruptly can develop adrenal crisis — hypotension, shock, vomiting — because exogenous steroid has suppressed their own hypothalamic-pituitary-adrenal axis, and the adrenal glands can't immediately resume normal cortisol output. Doses must be tapered.

Why It Matters: Corticosteroids are among the most widely used and most misused drugs in medicine — effective for almost any inflammatory condition, but with a long list of dose- and duration-dependent side effects.

Common Misunderstanding: Students often think steroid side effects only matter with "high doses." Even moderate doses used for more than 2-3 weeks can suppress the HPA axis and require a taper rather than abrupt discontinuation.

Key Terms

Term	Definition
Basal insulin	Long-acting insulin that provides steady background coverage between meals and overnight
Bolus insulin	Rapid- or short-acting insulin given to cover the glucose rise from a meal
AMPK	AMP-activated protein kinase; the enzyme metformin activates to reduce hepatic glucose production
Thyroid peroxidase	Enzyme that iodinates thyroglobulin during thyroid hormone synthesis; blocked by methimazole and PTU
HPA axis	Hypothalamic-pituitary-adrenal axis; the feedback loop controlling cortisol production, suppressed by chronic steroid use
Agranulocytosis	Severe drop in white blood cells; a rare but serious side effect of anti-thyroid drugs
Lactic acidosis	Rare but serious metformin complication from drug accumulation, usually in renal impairment
TSH	Thyroid-stimulating hormone; the main lab value used to titrate levothyroxine dosing

Common Mistakes

Misconception 1: "Metformin can cause hypoglycemia like insulin does." Why it's wrong: Metformin doesn't stimulate insulin secretion — it reduces hepatic glucose output and improves insulin sensitivity. Correct explanation: Hypoglycemia from metformin alone is essentially never seen; it's the sulfonylureas and insulin that carry that risk because they directly raise circulating insulin regardless of current glucose level.

Misconception 2: "A hypothyroid patient's levothyroxine dose can be checked a week or two after starting it." Why it's wrong: Levothyroxine has a long half-life (~7 days) and TSH changes lag behind serum T4 changes by weeks. Correct explanation: TSH should be rechecked no sooner than 4-6 weeks after any dose change, otherwise you'll misjudge the dose and overshoot.

Misconception 3: "Steroids can be stopped abruptly once symptoms improve." Why it's wrong: Exogenous steroids suppress the HPA axis, so the adrenal glands may not resume normal cortisol production immediately. Correct explanation: Courses longer than 2-3 weeks (or repeated short courses) need a gradual taper to allow the HPA axis to recover and avoid adrenal crisis.

Comparison and Connections

Drug/Class	Mechanism	Main Use	Key Risk
Insulin	Replaces hormone; activates GLUT4 glucose uptake	Type 1 DM, advanced type 2 DM	Hypoglycemia
Metformin	Activates AMPK, reduces hepatic gluconeogenesis	First-line type 2 DM	Lactic acidosis (rare)
Sulfonylureas	Close K-ATP channels, force insulin release	Type 2 DM (add-on)	Hypoglycemia, weight gain
Levothyroxine	Replaces T4, activates nuclear thyroid receptors	Hypothyroidism	Iatrogenic hyperthyroidism if overdosed
Methimazole/PTU	Inhibit thyroid peroxidase	Hyperthyroidism (Graves')	Agranulocytosis, hepatotoxicity (PTU)
Corticosteroids	Bind glucocorticoid receptor, alter gene transcription	Inflammation, autoimmune disease, adrenal insufficiency	HPA axis suppression, hyperglycemia, osteoporosis

Practice Questions

Recall

1. Name two rapid-acting insulin analogs and one long-acting insulin analog. Answer guidance: Rapid-acting — lispro, aspart, glulisine. Long-acting — glargine, detemir, degludec.

2. Which enzyme does methimazole inhibit? Answer guidance: Thyroid peroxidase, which is needed to iodinate thyroglobulin during thyroid hormone synthesis.

Understanding

3. Explain why metformin does not cause hypoglycemia when used as monotherapy. Answer guidance: It reduces hepatic gluconeogenesis and improves insulin sensitivity via AMPK activation rather than stimulating additional insulin secretion, so it lowers glucose only toward normal, not below it.

4. Why must corticosteroids be tapered rather than stopped abruptly after prolonged use? Answer guidance: Exogenous steroid suppresses the HPA axis; abrupt withdrawal can leave the body without adequate cortisol, risking adrenal crisis (hypotension, shock).

Application

5. A patient is scheduled for a CT scan with IV contrast and takes metformin daily. What should be considered? Answer guidance: Metformin is often held around the time of contrast administration and restarted after confirming renal function is stable, since contrast-induced nephropathy could allow metformin to accumulate and cause lactic acidosis.

6. A pregnant woman in her first trimester needs treatment for Graves' disease. Which anti-thyroid drug is preferred and why? Answer guidance: PTU, because methimazole is associated with a rare fetal scalp defect (aplasia cutis) when used in early pregnancy.

Analysis

7. Compare how sulfonylureas and metformin lower blood glucose, and explain why only one of them carries a significant hypoglycemia risk. Answer guidance: Sulfonylureas close K-ATP channels on beta cells, forcing insulin release regardless of current glucose level, so glucose can drop too low. Metformin lowers hepatic glucose output and improves sensitivity without directly raising insulin, so it can't push glucose below a safe floor on its own.

8. A patient with hypothyroidism started on levothyroxine three weeks ago has her TSH checked and it's still elevated. Is the dose necessarily wrong? Explain your reasoning. Answer guidance: Not necessarily — TSH takes 4-6 weeks to fully reflect a dose change because of levothyroxine's long half-life and the slow feedback response of the pituitary. Testing at 3 weeks is premature; the correct approach is to wait before adjusting the dose.

FAQ

1. Why can't insulin be given as a pill? Insulin is a protein, and digestive enzymes in the stomach and intestine would break it down before it could act, so it must be injected or infused.

2. Why is metformin first-line for type 2 diabetes instead of sulfonylureas? Metformin lowers blood glucose without causing hypoglycemia or weight gain, and it has good long-term cardiovascular safety data, whereas sulfonylureas carry hypoglycemia risk and promote weight gain.

3. Why does PTU get used in thyroid storm instead of methimazole? PTU has the extra benefit of blocking peripheral T4-to-T3 conversion, giving a faster reduction in the active hormone during a medical emergency, whereas methimazole only blocks new hormone synthesis.

4. Can you take levothyroxine with breakfast? It's better taken on an empty stomach 30-60 minutes before food, since food and calcium/iron supplements reduce its absorption and can lead to under-replacement.

5. Why do long-term steroids cause weight gain and high blood sugar? Glucocorticoids promote gluconeogenesis and fat redistribution while increasing appetite, so chronic use commonly causes hyperglycemia, central weight gain, and a Cushingoid appearance.

Quick Revision

• Insulin activates GLUT4 to move glucose into cells; can't be given orally because it's a protein.
• Rapid-acting insulins (lispro, aspart, glulisine) cover meals; long-acting (glargine, degludec) provide basal coverage.
• Metformin activates AMPK, reduces hepatic gluconeogenesis — does not cause hypoglycemia alone.
• Sulfonylureas force insulin release by closing K-ATP channels — hypoglycemia risk.
• SGLT2 inhibitors cause glucosuria; GLP-1 agonists slow gastric emptying and promote satiety.
• Levothyroxine (T4) treats hypothyroidism; dose titrated by TSH, rechecked no sooner than 4-6 weeks.
• Methimazole and PTU inhibit thyroid peroxidase; PTU also blocks peripheral T4→T3 conversion and is preferred in pregnancy (1st trimester) and thyroid storm.
• Both anti-thyroid drugs risk agranulocytosis — check WBC if fever/sore throat occurs.
• Corticosteroids bind glucocorticoid receptors, alter gene transcription, and suppress inflammation.
• Chronic steroid use suppresses the HPA axis — must be tapered, not stopped abruptly.
• Metformin is held around IV contrast administration due to lactic acidosis risk in renal impairment.
• Overtreated hypothyroidism (excess levothyroxine) causes iatrogenic hyperthyroidism, atrial fibrillation, and bone loss.

Related Topics

Prerequisites

• Basic endocrine physiology (hypothalamic-pituitary axes, feedback loops)
• Normal glucose homeostasis and insulin/glucagon physiology
• Thyroid hormone synthesis and regulation

Related Topics

• Diabetes mellitus: diagnosis, complications, and monitoring (HbA1c)
• Thyroid function tests and interpretation
• Adrenal insufficiency and Cushing's syndrome

Next Topics

• Reproductive and sex hormone pharmacology
• Drugs for osteoporosis and calcium/bone metabolism
• Pharmacology of the hypothalamic-pituitary axis (GH, prolactin, ADH analogs)